Breaking News, Collaborations & Alliances

Charles River to License Hera BioLab’s SRG Rat (OncoRat)

Charles River will breed, distribute, sell, and market the SRG rat directly to the preclinical research community.

Author Image

By: Charlie Sternberg

Associate Editor

Hera BioLabs, a service and technology provider with novel genetic engineering products, and Charles River Laboratories International Inc. have signed a global license agreement to commercialize Hera’s SRG rat (OncoRat), the first highly immunocompromised rat model, validated for xenograft studies in oncology and infectious disease research applications.   Under this new collaborative agreement, Charles River will breed, distribute, sell, and market the SRG rat directly to the preclinical rese...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters